Cargando…
PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
The repair of DNA damage is a critical cellular process governed by multiple biochemical pathways that are often found to be defective in cancer cells. The poly(ADP-ribose) polymerase (PARP) family of proteins controls response to single-strand DNA breaks by detecting these damaged sites and recruit...
Autores principales: | O’Sullivan Coyne, Geraldine, Chen, Alice P., Meehan, Robert, Doroshow, James H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266774/ https://www.ncbi.nlm.nih.gov/pubmed/28078645 http://dx.doi.org/10.1007/s40265-016-0688-7 |
Ejemplares similares
-
PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components
por: O’Sullivan Coyne, Geraldine, et al.
Publicado: (2022) -
Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity
por: Brown, Malcolm, et al.
Publicado: (2022) -
Theory to Practice: Performance Preparation Models in Contemporary High-Level Sport Guided by an Ecological Dynamics Framework
por: Woods, Carl T., et al.
Publicado: (2020) -
Advances in using PARP inhibitors to treat cancer
por: Kummar, Shivaani, et al.
Publicado: (2012) -
A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas
por: Meehan, Robert, et al.
Publicado: (2018)